1. Inhibition of insulin‐like growth factor 1 receptor enhances the efficacy of sorafenib in inhibiting hepatocellular carcinoma cell growth and survival
   Fang Wang et al, 2018, Hepatology Communications CrossRef
2. ALK and EGFR expression by immunohistochemistry are associated with Merkel cell polyomavirus status in Merkel cell carcinoma
   Tuukka Veija et al, 2019, Histopathology CrossRef
3. Systematic analysis of NLMP suggests nuclear localization of RTK/MET kinases resemble cancer cell clearance
   Yingqiu Xie et al, 2019, Journal of Experimental & Clinical Cancer Research CrossRef
4. Aberrant expression of ALK and EZH2 in Merkel cell carcinoma
   Tuukka Veija et al, 2017, BMC Cancer CrossRef
5. Inhibition of anaplastic lymphoma kinase promotes apoptosis and suppresses proliferation in human hepatocellular carcinoma
   Zhen Yu et al, 2018, Anti-Cancer Drugs CrossRef
6. ALK is frequently phosphorylated in Merkel cell carcinoma and associates with longer survival
   Jenni Jaatinen et al, 2021, PLOS ONE CrossRef
7. Clinical-Pathological Evaluation and Prognostic Analysis of 228 Merkel Cell Carcinomas Focusing on Tumor-Infiltrating Lymphocytes, MCPYV Infection and ALK Expression
   Federica Santoro et al, 2022, Endocrine Pathology CrossRef
8. Midkine promotes hepatocellular carcinoma metastasis by elevating anoikis resistance of circulating tumor cells
   Bin Sun et al, 2017, Oncotarget CrossRef